In-hospital outcomes in invasively managed acute myocardial infarction patients who receive morphine
We aimed to analyze the association between morphine and in-hospital outcomes in invasively managed ST elevation myocardial infarction (STEMI) and non-ST elevation acute coronary syndrome (NSTE-ACS) patients. Morphine is commonly used for analgesia in the setting of acute coronary syndromes (ACS); h...
Uloženo v:
| Vydáno v: | Journal of interventional cardiology Ročník 31; číslo 2; s. 150 |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
01.04.2018
|
| Témata: | |
| ISSN: | 1540-8183, 1540-8183 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | We aimed to analyze the association between morphine and in-hospital outcomes in invasively managed ST elevation myocardial infarction (STEMI) and non-ST elevation acute coronary syndrome (NSTE-ACS) patients.
Morphine is commonly used for analgesia in the setting of acute coronary syndromes (ACS); however, recently its utility in ACS has come under closer scrutiny.
We identified all STEMI and NSTE-ACS patients undergoing coronary angiogram +/- percutaneous intervention between January 2009 and July 2016 in our center and recorded patient characteristics and inpatient outcomes.
Overall, 3027 patients were examined. Overall, STEMI patients who received morphine had no difference in in-hospital mortality [4.18% vs. 7.54%, odds ratio (OR): 0.36, P = 0.19], infarct size (mean troponin level 0.75 ng/mL vs. 1.29 ng/mL, P = 0.32) or length of hospital stay (P = 0.61). The NSTE-ACS patients who received morphine had a longer hospital stay (mean 6.58 days vs. 4.78 days, P < 0.0001) and larger infarct size (mean troponin 1.16 ng/mL vs. 0.90 ng/mL, P = 0.02). Comparing matched patients, the use of morphine was associated with larger infarct size (mean troponin 1.14 ± 1.92 ng/mL vs. 0.83 ± 1.49 ng/mL, P = 0.01), longer hospital stay (6.5 ± 6.82 days vs. 4.89 ± 5.36 days, P = 0.004) and a trend towards increased mortality (5% vs. 2%, OR: 2.55, P = 0.06) in NSTE-ACS patients but morphine did not affect outcomes in the propensity matched STEMI patients.
In a large retrospective study, morphine was associated with larger infarct size, a longer hospital stay and a trend towards increased mortality in invasively managed NSTE-ACS patients even after adjustment for clinical characteristics. |
|---|---|
| AbstractList | We aimed to analyze the association between morphine and in-hospital outcomes in invasively managed ST elevation myocardial infarction (STEMI) and non-ST elevation acute coronary syndrome (NSTE-ACS) patients.
Morphine is commonly used for analgesia in the setting of acute coronary syndromes (ACS); however, recently its utility in ACS has come under closer scrutiny.
We identified all STEMI and NSTE-ACS patients undergoing coronary angiogram +/- percutaneous intervention between January 2009 and July 2016 in our center and recorded patient characteristics and inpatient outcomes.
Overall, 3027 patients were examined. Overall, STEMI patients who received morphine had no difference in in-hospital mortality [4.18% vs. 7.54%, odds ratio (OR): 0.36, P = 0.19], infarct size (mean troponin level 0.75 ng/mL vs. 1.29 ng/mL, P = 0.32) or length of hospital stay (P = 0.61). The NSTE-ACS patients who received morphine had a longer hospital stay (mean 6.58 days vs. 4.78 days, P < 0.0001) and larger infarct size (mean troponin 1.16 ng/mL vs. 0.90 ng/mL, P = 0.02). Comparing matched patients, the use of morphine was associated with larger infarct size (mean troponin 1.14 ± 1.92 ng/mL vs. 0.83 ± 1.49 ng/mL, P = 0.01), longer hospital stay (6.5 ± 6.82 days vs. 4.89 ± 5.36 days, P = 0.004) and a trend towards increased mortality (5% vs. 2%, OR: 2.55, P = 0.06) in NSTE-ACS patients but morphine did not affect outcomes in the propensity matched STEMI patients.
In a large retrospective study, morphine was associated with larger infarct size, a longer hospital stay and a trend towards increased mortality in invasively managed NSTE-ACS patients even after adjustment for clinical characteristics. We aimed to analyze the association between morphine and in-hospital outcomes in invasively managed ST elevation myocardial infarction (STEMI) and non-ST elevation acute coronary syndrome (NSTE-ACS) patients.OBJECTIVEWe aimed to analyze the association between morphine and in-hospital outcomes in invasively managed ST elevation myocardial infarction (STEMI) and non-ST elevation acute coronary syndrome (NSTE-ACS) patients.Morphine is commonly used for analgesia in the setting of acute coronary syndromes (ACS); however, recently its utility in ACS has come under closer scrutiny.BACKGROUNDMorphine is commonly used for analgesia in the setting of acute coronary syndromes (ACS); however, recently its utility in ACS has come under closer scrutiny.We identified all STEMI and NSTE-ACS patients undergoing coronary angiogram +/- percutaneous intervention between January 2009 and July 2016 in our center and recorded patient characteristics and inpatient outcomes.METHODSWe identified all STEMI and NSTE-ACS patients undergoing coronary angiogram +/- percutaneous intervention between January 2009 and July 2016 in our center and recorded patient characteristics and inpatient outcomes.Overall, 3027 patients were examined. Overall, STEMI patients who received morphine had no difference in in-hospital mortality [4.18% vs. 7.54%, odds ratio (OR): 0.36, P = 0.19], infarct size (mean troponin level 0.75 ng/mL vs. 1.29 ng/mL, P = 0.32) or length of hospital stay (P = 0.61). The NSTE-ACS patients who received morphine had a longer hospital stay (mean 6.58 days vs. 4.78 days, P < 0.0001) and larger infarct size (mean troponin 1.16 ng/mL vs. 0.90 ng/mL, P = 0.02). Comparing matched patients, the use of morphine was associated with larger infarct size (mean troponin 1.14 ± 1.92 ng/mL vs. 0.83 ± 1.49 ng/mL, P = 0.01), longer hospital stay (6.5 ± 6.82 days vs. 4.89 ± 5.36 days, P = 0.004) and a trend towards increased mortality (5% vs. 2%, OR: 2.55, P = 0.06) in NSTE-ACS patients but morphine did not affect outcomes in the propensity matched STEMI patients.RESULTSOverall, 3027 patients were examined. Overall, STEMI patients who received morphine had no difference in in-hospital mortality [4.18% vs. 7.54%, odds ratio (OR): 0.36, P = 0.19], infarct size (mean troponin level 0.75 ng/mL vs. 1.29 ng/mL, P = 0.32) or length of hospital stay (P = 0.61). The NSTE-ACS patients who received morphine had a longer hospital stay (mean 6.58 days vs. 4.78 days, P < 0.0001) and larger infarct size (mean troponin 1.16 ng/mL vs. 0.90 ng/mL, P = 0.02). Comparing matched patients, the use of morphine was associated with larger infarct size (mean troponin 1.14 ± 1.92 ng/mL vs. 0.83 ± 1.49 ng/mL, P = 0.01), longer hospital stay (6.5 ± 6.82 days vs. 4.89 ± 5.36 days, P = 0.004) and a trend towards increased mortality (5% vs. 2%, OR: 2.55, P = 0.06) in NSTE-ACS patients but morphine did not affect outcomes in the propensity matched STEMI patients.In a large retrospective study, morphine was associated with larger infarct size, a longer hospital stay and a trend towards increased mortality in invasively managed NSTE-ACS patients even after adjustment for clinical characteristics.CONCLUSIONIn a large retrospective study, morphine was associated with larger infarct size, a longer hospital stay and a trend towards increased mortality in invasively managed NSTE-ACS patients even after adjustment for clinical characteristics. |
| Author | Bhambhani, Vijeta Pomerantsev, Eugene McCarthy, Cian P Wasfy, Jason H |
| Author_xml | – sequence: 1 givenname: Cian P orcidid: 0000-0003-4944-0034 surname: McCarthy fullname: McCarthy, Cian P organization: Department of Medicine, Massachusetts General Hospital, Boston, MA – sequence: 2 givenname: Vijeta surname: Bhambhani fullname: Bhambhani, Vijeta organization: Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, MA – sequence: 3 givenname: Eugene surname: Pomerantsev fullname: Pomerantsev, Eugene organization: Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, MA – sequence: 4 givenname: Jason H surname: Wasfy fullname: Wasfy, Jason H organization: Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, MA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29166703$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkEtrwzAQhEVJaR7tpT-g6NiLU8mWZflYQh-BQC-5G1laNQq25Ep2Sv59BU2hw8LO4ZtlmSWaOe8AoXtK1jTp6eitWtOccXaFFrRkJBNUFLN_fo6WMR4JyUlZ5jdonteU84oUC6S3Ljv4ONhRdthPo_I9RGxdmpOM9gTdGffSyU_QWKppBNyfvZJB28RbZ2RQo_UOD3K04MaIvw8eB1CQorj3YThYB7fo2sguwt1lr9D-9WW_ec92H2_bzfMuU6xiLNOyMnULXLU1L6nRQEzZVlRQRQqiCGGFKSrTclFLAul_ZogAoUuRIiXN8xV6_D07BP81QRyb3kYFXScd-Ck2tOaV4JQKltCHCzq1PehmCLaX4dz8FZP_AP5BZ_c |
| CitedBy_id | crossref_primary_10_1016_j_ijcard_2021_02_037 crossref_primary_10_1371_journal_pone_0245433 crossref_primary_10_1038_s41598_019_40628_0 crossref_primary_10_1002_cpt_1798 crossref_primary_10_4236_ojn_2025_158044 crossref_primary_10_1016_j_ajem_2023_05_010 crossref_primary_10_1016_j_jacc_2019_11_035 crossref_primary_10_1136_openhrt_2020_001307 crossref_primary_10_1016_j_ejphar_2025_177736 crossref_primary_10_3892_mmr_2018_9335 crossref_primary_10_1136_bmjopen_2018_025232 crossref_primary_10_1136_heartasia_2018_011142 crossref_primary_10_1016_j_ejphar_2024_176648 crossref_primary_10_1016_j_ijcard_2020_08_064 crossref_primary_10_1007_s42399_021_01046_4 crossref_primary_10_1016_j_ahj_2022_05_005 crossref_primary_10_1177_10468781251316889 crossref_primary_10_1016_j_ejphar_2022_175094 crossref_primary_10_1007_s44254_024_00071_5 |
| ContentType | Journal Article |
| Copyright | 2017, Wiley Periodicals, Inc. |
| Copyright_xml | – notice: 2017, Wiley Periodicals, Inc. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1111/joic.12464 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1540-8183 |
| ExternalDocumentID | 29166703 |
| Genre | Journal Article |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GrantInformation_xml | – fundername: NCATS NIH HHS grantid: UL1 TR001102 – fundername: NCATS NIH HHS grantid: KL2 TR001100 |
| GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 24P 29K 31~ 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 8FI 8FJ 8UM 930 A01 A03 AAESR AAEVG AAJEY AAMMB AANHP AAONW AAWTL AAZKR ABCQN ABDBF ABEML ABJNI ABOCM ABPVW ABUWG ACBWZ ACCMX ACGFS ACMXC ACPRK ACRPL ACSCC ACUHS ACXQS ACYXJ ADBBV ADEOM ADIZJ ADNMO AEFGJ AEIMD AENEX AFBPY AFEBI AFKRA AFZJQ AGQPQ AGXDD AHEFC AIDQK AIDYY ALAGY ALIPV ALMA_UNASSIGNED_HOLDINGS AMBMR ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BCNDV BDRZF BENPR BHBCM BMXJE BPHCQ BPMNR BROTX BRXPI BVXVI BY8 CAG CCPQU CGR COF CS3 CUY CVF D-6 D-7 D-E D-F D-I DC6 DCZOG DPXWK DR2 DU5 EAD EAP EAS EBD EBS ECM EIF EJD EMB EMK EMOBN ENC EPT ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FYUFA FZ0 G-S G.N GODZA GROUPED_DOAJ H.X HF~ HMCUK HVGLF HYE HZI HZ~ IAO IHE IHR INH ITC IX1 J0M K48 LC2 LC3 LH4 LITHE LOXES LP6 LP7 LUTES LW6 MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM N04 N05 N9A NF~ NPM O66 O9- OIG OK1 OVD P2W P2X P2Z P4B P4D PALCI PGMZT PHGZM PHGZT PIMPY PQQKQ Q.N Q11 QB0 Q~Q R.K RIWAO RJQFR ROL RPM RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 UKHRP W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WVDHM WXI WXSBR XG1 ZZTAW ~IA ~WT 7X8 |
| ID | FETCH-LOGICAL-c4744-da7f9be6cb9651fde0f5b7181c030c0043f37fb689a0e6674f08e8d58e6c5122 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 21 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000430006700005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1540-8183 |
| IngestDate | Thu Oct 02 11:52:21 EDT 2025 Mon Jul 21 05:53:22 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | STEMI NTE-ACS morphine |
| Language | English |
| License | 2017, Wiley Periodicals, Inc. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4744-da7f9be6cb9651fde0f5b7181c030c0043f37fb689a0e6674f08e8d58e6c5122 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0003-4944-0034 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/joic.12464 |
| PMID | 29166703 |
| PQID | 1967861184 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1967861184 pubmed_primary_29166703 |
| PublicationCentury | 2000 |
| PublicationDate | April 2018 |
| PublicationDateYYYYMMDD | 2018-04-01 |
| PublicationDate_xml | – month: 04 year: 2018 text: April 2018 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Journal of interventional cardiology |
| PublicationTitleAlternate | J Interv Cardiol |
| PublicationYear | 2018 |
| SSID | ssj0020552 |
| Score | 2.2628236 |
| Snippet | We aimed to analyze the association between morphine and in-hospital outcomes in invasively managed ST elevation myocardial infarction (STEMI) and non-ST... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 150 |
| SubjectTerms | Acute Coronary Syndrome - diagnosis Acute Coronary Syndrome - drug therapy Acute Coronary Syndrome - mortality Acute Coronary Syndrome - surgery Aged Analgesics, Opioid - administration & dosage Analgesics, Opioid - adverse effects Female Hospital Mortality Humans Length of Stay Male Middle Aged Morphine - administration & dosage Morphine - adverse effects Odds Ratio Outcome and Process Assessment, Health Care Percutaneous Coronary Intervention - adverse effects Percutaneous Coronary Intervention - methods Retrospective Studies ST Elevation Myocardial Infarction - diagnosis ST Elevation Myocardial Infarction - drug therapy ST Elevation Myocardial Infarction - mortality ST Elevation Myocardial Infarction - surgery United States - epidemiology |
| Title | In-hospital outcomes in invasively managed acute myocardial infarction patients who receive morphine |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/29166703 https://www.proquest.com/docview/1967861184 |
| Volume | 31 |
| WOSCitedRecordID | wos000430006700005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7Uinjx_agvVvAaTZvN7uYkIhY9tPTQQ28h-6KFNqmmrfTfO5Ns9SQIQsgpk4Sd17c7w3yE3BmWIPGbCgyDvQnDYUMy4izIwCtDaxADyIpsQvR6cjhM-v7ArfRtleuYWAVqU2g8I38ASxGSAxxmj7P3AFmjsLrqKTQ2SSMCKIMtXWL4XUVoh3HFuNPC4j8kpsiPJ606eYqxvofchpMGfoOWVYrp7P_35w7IngeX9Km2hkOyYfMjstP15fNjYt7yYOSJQmixmMPLbUnHOVzLDPvYJytat7MamunF3NLpCnId2tAEnnHgFKhH6oexlvRzVFAImRZE6bQAlcFnTsig8zJ4fg08zUKgmWAsMJlwibJcq4THLWds6GIFKaulIQBoLBW6SDjFZZKFlnPBXCitNLEEEYAL7VOylRe5PSeUK-eEgk2KNSFuvJTAaTFgBEJwxZhuktv18qVgxViayHJbLMr0ZwGb5KzWQTqrx22kbUCwHALTxR-kL8kuIBpZt9ZckYYDH7bXZFsv5-Py46YyD7j3-t0v4_3Fjg |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In-hospital+outcomes+in+invasively+managed+acute+myocardial+infarction+patients+who+receive+morphine&rft.jtitle=Journal+of+interventional+cardiology&rft.au=McCarthy%2C+Cian+P&rft.au=Bhambhani%2C+Vijeta&rft.au=Pomerantsev%2C+Eugene&rft.au=Wasfy%2C+Jason+H&rft.date=2018-04-01&rft.eissn=1540-8183&rft.volume=31&rft.issue=2&rft.spage=150&rft_id=info:doi/10.1111%2Fjoic.12464&rft_id=info%3Apmid%2F29166703&rft_id=info%3Apmid%2F29166703&rft.externalDocID=29166703 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1540-8183&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1540-8183&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1540-8183&client=summon |